These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15250270)

  • 41. Quality of water used for haemodialysis: bacterial and chemical parameters. I. Vorbeck-Meister et al. Nephrology, Dialysis and Transplantation, 1999 14 666-675.
    EDTNA ERCA J; 1999; 25(4):24-5. PubMed ID: 10827594
    [No Abstract]   [Full Text] [Related]  

  • 42. [Recent advances in the treatment of fulminant hepatitis B].
    Yoshiba M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():280-3. PubMed ID: 15453330
    [No Abstract]   [Full Text] [Related]  

  • 43. Medical nutrition therapy when kidney disease meets liver failure.
    Cotton AB
    Nephrol Nurs J; 2007; 34(6):661-2. PubMed ID: 18203576
    [No Abstract]   [Full Text] [Related]  

  • 44. HBV-related fulminant hepatic failure: successful intensive medical therapy in a candidate for liver transplantation.
    Masuhara M; Yagawa T; Aoyagi M; Suzuki C; Sakaguchi E; Segawa M; Hironaka K; Kayano K; Tamura F; Seguchi M; Soejima Y; Murakami F; Sakaida I; Tateishi A; Fukumoto Y; Okita K
    J Gastroenterol; 2001 May; 36(5):350-3. PubMed ID: 11388400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sodium setpoint and sodium gradient: influence on plasma sodium change and weight gain.
    Hecking M; Kainz A; Hörl WH; Herkner H; Sunder-Plassmann G
    Am J Nephrol; 2011; 33(1):39-48. PubMed ID: 21160174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Falsely low calcium measurements after high volume plasma exchange in a patient with liver failure.
    Miller JP; Mintz PD
    Transfus Sci; 1994 Sep; 15(3):299-302. PubMed ID: 10161259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Chronic hepatitis B infection and liver failure following kidney transplantation].
    Christen R; Blumberg A; Pirovino M
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2523-5. PubMed ID: 8571106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Continuous hemodialysis with cuprophan membranes in critical patients].
    Cotera A; Lorca E; Saffie A; Sepulveda M
    Rev Med Chil; 1994 Apr; 122(4):394-400. PubMed ID: 7809533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ineffectiveness of dialysis in transthyretin (TTR) clearance in familial amyloid polyneuropathy type I, in spite of lower stability of the TTR Met30 variant.
    Beirão I; Lobato L; Riedstra S; Costa PM; Pimentel S; Guimarães S
    Clin Nephrol; 1999 Jan; 51(1):45-9. PubMed ID: 9988146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients.
    Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Oimomi M; Goto T
    J Gastroenterol; 2003; 38(10):968-76. PubMed ID: 14614604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews.
    MacLeod A; Grant A; Donaldson C; Khan I; Campbell M; Daly C; Lawrence P; Wallace S; Vale L; Cody J; Fitzhugh K; Montague G; Ritchie C
    Health Technol Assess; 1998; 2(5):1-166. PubMed ID: 9621129
    [No Abstract]   [Full Text] [Related]  

  • 52. Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function.
    Morath C; Miftari N; Dikow R; Hainer C; Zeier M; Morgera S; Weigand MA; Schwenger V
    Nephrol Dial Transplant; 2008 Jan; 23(1):421-2. PubMed ID: 17913732
    [No Abstract]   [Full Text] [Related]  

  • 53. Development of reliable artificial liver support (ALS)--plasma exchange in combination with hemodiafiltration using high-performance membranes.
    Yoshiba M; Sekiyama K; Iwamura Y; Sugata F
    Dig Dis Sci; 1993 Mar; 38(3):469-76. PubMed ID: 8444078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Plasma purification (characteristics, indication and recent development)].
    Agishi T
    Nihon Rinsho; 2004 May; 62 Suppl 5():307-12. PubMed ID: 15197935
    [No Abstract]   [Full Text] [Related]  

  • 55. [Blood purification therapies for burn patients].
    Tarui T; Murata A; Shimazaki S
    Nihon Rinsho; 2004 May; 62 Suppl 5():519-22. PubMed ID: 15197976
    [No Abstract]   [Full Text] [Related]  

  • 56. [Blood purification for severe acute pancreatitis].
    Moriguchi T; Hirasawa H; Oda S
    Nihon Rinsho; 2004 May; 62 Suppl 5():467-71. PubMed ID: 15197965
    [No Abstract]   [Full Text] [Related]  

  • 57. On-Line Hemodiafiltration: All That Glitters Is Not Gold.
    Marano M; Capasso M; Cicchella T
    Blood Purif; 2016; 41(4):315-6. PubMed ID: 26859635
    [No Abstract]   [Full Text] [Related]  

  • 58. [Early diagnosis for hepatitis severity and fulminant hepatitis in patients with acute hepatitis(type B): biochemical, physiological and physical methods].
    Watanabe A
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):502-9. PubMed ID: 12442435
    [No Abstract]   [Full Text] [Related]  

  • 59. Extrahepatic implications of metabolic syndrome.
    Watt KD
    Liver Transpl; 2013 Nov; 19 Suppl 2():S56-61. PubMed ID: 23960041
    [No Abstract]   [Full Text] [Related]  

  • 60. Hemodiafiltration--an avenue to shorter dialysis?
    Wizemann V
    Contrib Nephrol; 1985; 44():49-56. PubMed ID: 3987292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.